Integrating Phylodynamics and Epidemiology to Estimate Transmission Diversity in Viral Epidemics

The epidemiology of chronic viral infections, such as those caused by Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV), is affected by the risk group structure of the infected population. Risk groups are defined by each of their members having acquired infection through a specific behavior. However, risk group definitions say little about the transmission potential of each infected individual. Variation in the number of secondary infections is extremely difficult to estimate for HCV and HIV but crucial in the design of efficient control interventions. Here we describe a novel method that combines epidemiological and population genetic approaches to estimate the variation in transmissibility of rapidly-evolving viral epidemics. We evaluate this method using a nationwide HCV epidemic and for the first time co-estimate viral generation times and superspreading events from a combination of molecular and epidemiological data. We anticipate that this integrated approach will form the basis of powerful tools for describing the transmission dynamics of chronic viral diseases, and for evaluating control strategies directed against them.

[1]  M A Gerber,et al.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. , 1992, The New England journal of medicine.

[2]  E. Kenny‐Walsh.  Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. , 1999, The New England journal of medicine.

[3]  J. Emparanza,et al.  [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.

[4]  Louisa Degenhardt,et al.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.

[5]  H. Klein,et al.  The hazards of blood transfusion in historical perspective. , 2008, Blood.

[6]  J. Lloyd-Smith.  Maximum Likelihood Estimation of the Negative Binomial Dispersion Parameter for Highly Overdispersed Data, with Applications to Infectious Diseases , 2007, PloS one.

[7]  C. J. Rhodes,et al.  The effect of superspreading on epidemic outbreak size distributions. , 2008, Journal of theoretical biology.

[8]  P. Hedrick.  LARGE VARIANCE IN REPRODUCTIVE SUCCESS AND THE Ne/N RATIO , 2005, Evolution; international journal of organic evolution.

[9]  W. O. Kermack,et al.  A contribution to the mathematical theory of epidemics , 1927 .

[10]  H. Margolis,et al.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. , 1990, JAMA.

[11]  L. Seeff,et al.  45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults , 2000, Annals of Internal Medicine.

[12]  R. May,et al.  Population biology of infectious diseases: Part II , 1979, Nature.

[13]  M. Massari,et al.  Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Motoo Kimura,et al.  THE MEASUREMENT OF EFFECTIVE POPULATION NUMBER , 1963 .

[15]  R. Purcell,et al.  A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. , 1991, The New England journal of medicine.

[16]  A. Valleron,et al.  Modeling the hepatitis C virus epidemic in france , 1999, Hepatology.

[17]  L. Avanesyan,et al.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. , 2009, The Journal of infectious diseases.

[18]  M. Alter,et al.  Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006. , 2011, Archives of internal medicine.

[19]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[20]  R. May,et al.  Population Biology of Infectious Diseases , 1982, Dahlem Workshop Reports.

[21]  M. Buti,et al.  A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[22]  A. Rambaut,et al.  BEAST: Bayesian evolutionary analysis by sampling trees , 2007, BMC Evolutionary Biology.

[23]  N. Grassly,et al.  Mathematical models of infectious disease transmission , 2008, Nature Reviews Microbiology.

[24]  O. Pybus,et al.  The Epidemic Behavior of the Hepatitis C Virus , 2001, Science.

[25]  R. May,et al.  Population biology of infectious diseases: Part I , 1979, Nature.

[26]  J. Kingman.  On the genealogy of large populations , 1982, Journal of Applied Probability.

[27]  C. Rui.  Genetic variation in IL-28B and spontaneous clearance of hepatitis C virus , 2012 .

[28]  D. Vlahov,et al.  Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  W. Newey,et al.  A Simple, Positive Semi-Definite, Heteroskedasticity and Autocorrelationconsistent Covariance Matrix , 1986 .

[30]  G. Cabibbo,et al.  Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. , 2008, Gastroenterology.

[31]  O. Pybus,et al.  Impact of HIV on host-virus interactions during early hepatitis C virus infection. , 2008, Journal of Infectious Diseases.

[32]  S. Ho,et al.  Relaxed Phylogenetics and Dating with Confidence , 2006, PLoS biology.

[33]  M. Raptopoulou-Gigi,et al.  Prevalence of hepatitis C virus infection in a cohort of pregnant women in northern Greece and transmission of HCV from mother to child , 2004, European Journal of Epidemiology.

[34]  H. Margolis,et al.  The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States , 2000, Hepatology.

[35]  O. Pybus,et al.  The Global Spread of Hepatitis C Virus 1a and 1b: A Phylodynamic and Phylogeographic Analysis , 2009, PLoS medicine.

[36]  D. Vlahov,et al.  The natural history of hepatitis C virus infection: host, viral, and environmental factors. , 2000, JAMA.

[37]  C. Wilke,et al.  Contact Heterogeneity and Phylodynamics: How Contact Networks Shape Parasite Evolutionary Trees , 2010, Interdisciplinary perspectives on infectious diseases.

[38]  A. Hatzakis,et al.  Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees , 2004, European Journal of Epidemiology.

[39]  B. Grenfell,et al.  Protocols for sampling viral sequences to study epidemic dynamics , 2010, Journal of The Royal Society Interface.

[40]  M. Keeling,et al.  Modeling Infectious Diseases in Humans and Animals , 2007 .

[41]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[42]  J. Hess,et al.  Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. , 1999, Clinical pediatrics.

[43]  M. Lipsitch,et al.  How generation intervals shape the relationship between growth rates and reproductive numbers , 2007, Proceedings of the Royal Society B: Biological Sciences.

[44]  K. Shianna,et al.  A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. , 2010, Gastroenterology.

[45]  P. E. Kopp,et al.  Superspreading and the effect of individual variation on disease emergence , 2005, Nature.

[46]  W. Newey,et al.  A Simple, Positive Semi-Definite, Heteroskedasticity and Autocorrelationconsistent Covariance Matrix , 1986 .

[47]  K. Strimmer,et al.  Exploring the demographic history of DNA sequences using the generalized skyline plot. , 2001, Molecular biology and evolution.

[48]  Roy M. Anderson,et al.  Transmission dynamics of HIV infection , 1987, Nature.

[49]  O. Pybus,et al.  Unifying the Epidemiological and Evolutionary Dynamics of Pathogens , 2004, Science.

[50]  Erik M. Volz,et al.  Viral phylodynamics and the search for an ‘effective number of infections’ , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.

[51]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[52]  A. Hatzakis,et al.  Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection , 2004, Journal of viral hepatitis.

[53]  K. Mimidis,et al.  HCV infection in the general population of a Greek island: prevalence and risk factors. , 2000, Hepato-Gastroenterology.

[54]  G. Magiorkinis,et al.  Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype‐specific incidence and molecular characterization of genotype 4 isolates , 2006, Journal of viral hepatitis.

[55]  J. Goedert,et al.  Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. , 2005, Blood.

[56]  M. Pfaffl,et al.  Standardized determination of real-time PCR efficiency from a single reaction set-up. , 2003, Nucleic acids research.

[57]  H J Alter,et al.  Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome , 2000, Seminars in liver disease.

[58]  M. Kudo,et al.  Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan , 2010, Intervirology.

[59]  C. Dye,et al.  Heterogeneities in the transmission of infectious agents: implications for the design of control programs. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Carol Y. Lin,et al.  Modeling Infectious Diseases in Humans and Animals by KEELING, M. J. and ROHANI, P. , 2008 .

[61]  Katia Koelle,et al.  Rates of coalescence for common epidemiological models at equilibrium , 2012, Journal of The Royal Society Interface.

[62]  E. Lawlor,et al.  Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. , 1999, The New England journal of medicine.

[63]  Sergei L. Kosakovsky Pond,et al.  Phylodynamics of Infectious Disease Epidemics , 2009, Genetics.

[64]  J. Margolick,et al.  Blood and plasma donations among a cohort of intravenous drug users. , 1990, JAMA.

[65]  J. Felsenstein,et al.  Inbreeding and variance effective numbers in populations with overlapping generations. , 1971, Genetics.

[66]  P. Donnelly,et al.  Inferring coalescence times from DNA sequence data. , 1997, Genetics.

[67]  J. M. Calvo Romero,et al.  Gastric adenocarcinoma and kidney transplantation , 1998 .

[68]  D. D. Des Jarlais,et al.  Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. , 2008, American journal of epidemiology.

[69]  E L Murphy,et al.  Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.

[70]  Huldrych F. Günthard,et al.  Inferring Epidemic Contact Structure from Phylogenetic Trees , 2012, PLoS Comput. Biol..

[71]  M. Alter.  HCV routes of transmission: what goes around comes around. , 2011, Seminars in liver disease.

[72]  J W Shih,et al.  Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. , 1996, The New England journal of medicine.